PTCT - PTC Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PTCT is currently covered by 12 analysts with an average price target of $79.83. This is a potential upside of $15.03 (23.19%) from yesterday's end of day stock price of $64.8.

PTC Therapeutics's activity chart (see below) currently has 275 price targets and 226 ratings on display. The stock rating distribution of PTCT is 17.5% HOLD, 67.5% BUY and 15% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.64% with an average time for these price targets to be met of 311 days.

Highest price target for PTCT is $118, Lowest price target is $40, average price target is $66.82.

Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 03-Sep-2025. First documented stock forecast 14-Feb-2014.

Currently out of the existing stock ratings of PTCT, 7 are a HOLD (17.5%), 27 are a BUY (67.5%), 6 are a SELL (15%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$118

$52.63 (80.51%)

$120

1 months 3 days ago
(03-Sep-2025)

10/19 (52.63%)

$62.45 (112.42%)

362

Buy

$71

$5.63 (8.61%)

$70

1 months 16 days ago
(20-Aug-2025)

8/12 (66.67%)

$22.15 (45.34%)

170

Buy

$76

$10.63 (16.26%)

$84

1 months 16 days ago
(20-Aug-2025)

9/13 (69.23%)

$27.15 (55.58%)

23

Hold

$46

$-19.37 (-29.63%)

$42

2 months 7 days ago
(29-Jul-2025)

13/16 (81.25%)

$-3.29 (-6.67%)

259

Buy

$80

$14.63 (22.38%)

3 months 19 days ago
(17-Jun-2025)

3/4 (75%)

$29.15 (57.33%)

704

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PTCT (PTC Therapeutics) average time for price targets to be met?

On average it took 311 days on average for the stock forecasts to be realized with a an average price target met ratio 65.64

Which analyst has the current highest performing score on PTCT (PTC Therapeutics) with a proven track record?

KRISTEN KLUSKA

Which analyst has the most public recommendations on PTCT (PTC Therapeutics)?

Kristen Kluska works at CANTOR FITZGERALD and has 2 price targets and 4 ratings on PTCT

Which analyst is the currently most bullish on PTCT (PTC Therapeutics)?

Kristen Kluska with highest potential upside - $52.63

Which analyst is the currently most reserved on PTCT (PTC Therapeutics)?

Heather Behanna with lowest potential downside - -$53.37

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?